Copyright Lately

AUGUST 22, 2021

Liebowitz is probably the best known example of a copyright troll, a moniker that one circuit court defined as a someone who brings “strategic infringement claims of dubious merit in the hope of arranging prompt settlements with defendants who would prefer to pay modest or nuisance settlements rather than be tied up in expensive litigation.”.

Copyright 87

Copyright Fair Use Settlement Designs 87

SpicyIP

MARCH 11, 2024

Calm Water Therapeutics Llc vs The Assistant Controller Of Patents And Designs on 28 February, 2024 (Delhi High Court) The appeal challenged the rejection of a patent application for a “Bi-Functional Co-Polymer” by the Assistant Controller of Patents.

Trademark 59

Trademark Registration Copyright Patent 59

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

The biosimilar pathway was designed to increase competition for biologics and reduce healthcare costs. For the first time since FDA licensed the first biosimilar, Sandoz’s Zarxio ® (filgrastim-sndz), in 2015, the United States saw a decrease in annual biosimilar approvals in 2020. No earlier than July 31, 2023 per settlement.

Settlement 52

Settlement Litigation Marketing Marketing 52

The IPKat

SEPTEMBER 12, 2021

The UK launch of the Freestyle Libre 3 is said to be confidential, but the G7 is intended to be launched this autumn 2021. This followed the end of the parties peace agreement provided for by a settlement agreement following the last bout of litigation. In Germany, Abbott has already launched the Freestyle Libre 3.

Litigation 98

Litigation Patent Marketing Marketing 98

LexBlog IP

APRIL 3, 2023

This decision indicates that an SEP owner sometimes might need to provide information to a prospective licensee (under a confidentiality agreement), although that may not be necessary for an experienced licensee who can consult existing patent licenses they have entered with others. non-discriminatory] part of FRAND).

Licensing 52

Licensing Technology Intellectual Property Patent 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology biosimilar. Figure 1 below provides an overview of biosimilar approvals by FDA and product launches in the United States from 2015 to 2021. Introduction.

Litigation 52

Litigation Settlement Patent Marketing 52

LexBlog IP

JUNE 7, 2023

SEP Registration The Proposal establishes a “Competence Centre” within the EUIPO (which currently focuses solely on trademarks and design rights) to set up and maintain an EU-wide register for SEPs. Confidential nature of the EUIPO’s findings. ZTE (2015) ECLI: EU:C:2015:477. [33] 24] Article 53. [25]

Licensing 52

Licensing Patent Confidentiality Registration 52